Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

January 31, 2006

Last Updated Date

December 14, 2007

Start Date ^†

August 2005

Current Primary Outcome Measures ^†

Beck Depression Inventory

Original Primary Outcome Measures ^†

Same as current

Change History

Complete list of historical versions of study NCT00285740 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

NDDI

Original Secondary Outcome Measures ^†

Same as current

Descriptive Information

Brief Title ^†

Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting

Official Title ^†

Brief Summary

This study involves a form of group therapy called Cognitive Behavioral Therapy or CBT for depressed patients with Epilepsy. The CBT groups will be tailored for an epilepsy clinic population. There are 12 sessions of therapy in the study held once a week for 12 weeks.

Detailed Description

Depression is frequent in PWE and often missed for unclear reasons. Busy neurology clinics and their overworked physicians often lack psychiatric backup that may make inquiring about psychological issues problematic. In the psychiatric community, awareness of the need for depression intervention in the primary care clinic has been recognized for many years and several treatment models exist. This study will attempt to use one such model, i.e.

Cognitive-Behavioral Therapy (CBT) using a group format and tailoring its use for an epilepsy clinic population.

Study Phase

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Condition ^†

Epilepsy
Depressive Disorder

Intervention ^†

Behavioral: Cognitive Behavioral Therapy (CBT) in a Group Format

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Active, not recruiting

Enrollment ^†

Completion Date

January 2007

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria::- Patients will be screened with the Beck Depression Inventory. Those reaching the positive cut-off score of 11 (indicating at least a mild depression) will be entered into the study. Patients entered on antidepressants will be held at a stable dosage. Anti-epileptic drugs will also be maintained on the same dosage at entry into the study when possible clinically, after consultation with their neurologist. Exclusion Criteria:- Patients will be excluded if there is any active serious medical conditions, Standard Score<70 as assessed via the Wide Range Achievement Test, psychotic or substance abuse issues, those who are unable to maintain a stable dose of medications for the duration of study.

Gender

Both

Ages

18 Years to 65 Years

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00285740

Responsible Party

Secondary IDs ^††

34121

Study Sponsor ^†

Stanford University

Collaborators ^††

Epilepsy Foundation

Investigators ^†

Principal Investigator:

John J Barry

Stanford University

Information Provided By

Stanford University

Verification Date

December 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.